Cancer patients who respond to durvalumab can keep getting it in this Follow-Up study

NCT ID NCT05303532

ENROLLING_BY_INVITATION Disease control Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 28 times

Summary

This study offers continued treatment with durvalumab to cancer patients who have already completed a previous study and are still benefiting from the drug, as judged by their doctor. About 214 participants will be enrolled to monitor safety and side effects over time. The goal is to allow ongoing access to a treatment that is working for them.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Research Site

Newport Beach, California, 92663, United States
Research Site

Denver, Colorado, 80218, United States
Research Site

Memphis, Tennessee, 38120, United States
Research Site

Rosario, S2000KZE, Argentina
Research Site

Box Hill, 3128, Australia
Research Site

Melbourne, 3000, Australia
Research Site

Charleroi, 6000, Belgium
Research Site

Barretos, 14784-400, Brazil
Research Site

São José do Rio Preto, 15090-000, Brazil
Research Site

Sofia, 1612, Bulgaria
Research Site

Sofia, 1618, Bulgaria
Research Site

Kingston, Ontario, K7L 2V7, Canada
Research Site

Newmarket, Ontario, L3Y 2P9, Canada
Research Site

Toronto, Ontario, M5G 2M9, Canada
Research Site

Beijing, 100142, China
Research Site

Changsha, 410013, China
Research Site

Hangzhou, 310003, China
Research Site

Hangzhou, 310009, China
Research Site

Nanjing, 210009, China
Research Site

Shanghai, 200030, China
Research Site

Shenyang, 110042, China
Research Site

Wenzhou, 325000, China
Research Site

Xi'an, 710061, China
Research Site

Xiamen, 361003, China
Research Site

Olomouc, 779 00, Czechia
Research Site

Besançon, 25030, France
Research Site

Bordeaux, 33076, France
Research Site

Brest, 29200, France
Research Site

Dijon, 21079, France
Research Site

Lyon, 69373, France
Research Site

Marseille, 13005, France
Research Site

Montpellier, 34090, France
Research Site

Rennes, 35042, France
Research Site

Rouen, 76031, France
Research Site

Saint-Herblain, 44805, France
Research Site

Strasbourg, 67200, France
Research Site

Toulouse, 31059, France
Research Site

Tours, 37044, France
Research Site

Villejuif, 94805, France
Research Site

Gütersloh, 33332, Germany
Research Site

Münster, 48149, Germany
Research Site

Oldenburg, 26121, Germany
Research Site

Athens, 14564, Greece
Research Site

Budapest, 1083, Hungary
Research Site

Győr, 9024, Hungary
Research Site

Székesfehérvár, 8000, Hungary
Research Site

Chennai, 600035, India
Research Site

Arezzo, 52100, Italy
Research Site

Bari, 70124, Italy
Research Site

Catania, 95126, Italy
Research Site

Meldola, 47014, Italy
Research Site

Milan, 20141, Italy
Research Site

Modena, 41125, Italy
Research Site

Padova, 35128, Italy
Research Site

Pisa, 56126, Italy
Research Site

Roma, 00128, Italy
Research Site

Roma, 00152, Italy
Research Site

Bunkyō City, 113-8677, Japan
Research Site

Fukuoka, 812-8582, Japan
Research Site

Kanazawa, 920-8641, Japan
Research Site

Kōtoku, 135-8550, Japan
Research Site

Nagoya, 466-8560, Japan
Research Site

Okayama, 700-8607, Japan
Research Site

Saga, 840-8571, Japan
Research Site

Sunto-gun, 411-8777, Japan
Research Site

Kuching, 93200, Malaysia
Research Site

Aguascalientes, 20230, Mexico
Research Site

Mexico City, 0 3100, Mexico
Research Site

Mérida, 97134, Mexico
Research Site

Quezon City, 1101, Philippines
Research Site

Bialystok, 15-027, Poland
Research Site

Bydgoszcz, 85-796, Poland
Research Site

Elblag, 02-300, Poland
Research Site

Lodz, 90-302, Poland
Research Site

Lodz, 93-513, Poland
Research Site

Olsztyn, 10-357, Poland
Research Site

Szczecin, 71-730, Poland
Research Site

Warsaw, 02-781, Poland
Research Site

Suceava, 720214, Romania
Research Site

Moscow, 105229, Russia
Research Site

Moscow, 115478, Russia
Research Site

Nizhny Novgorod, 603001, Russia
Research Site

Novosibirsk, 630108, Russia
Research Site

Omsk, 644013, Russia
Research Site

Saint Petersburg, 196603, Russia
Research Site

Saint Petersburg, 197758, Russia
Research Site

Busan, 49241, South Korea
Research Site

Gwangju, 61469, South Korea
Research Site

Seoul, 03080, South Korea
Research Site

Seoul, 03722, South Korea
Research Site

Seoul, 06351, South Korea
Research Site

Barcelona, 08025, Spain
Research Site

Barcelona, 08035, Spain
Research Site

Girona, 17007, Spain
Research Site

Madrid, 28046, Spain
Research Site

Marbella, 29603, Spain
Research Site

Santiago de Compostela, 15706, Spain
Research Site

Valencia, 46009, Spain
Research Site

Lausanne, CH-1011, Switzerland
Research Site

Taichung, 404, Taiwan
Research Site

Taichung, 40705, Taiwan
Research Site

Tainan, 704, Taiwan
Research Site

Taipei, 112, Taiwan
Research Site

Taoyuan, 333, Taiwan
Research Site

Bangkok, 10330, Thailand
Research Site

Chiang Mai, 50200, Thailand
Research Site

Hat Yai, 90110, Thailand
Research Site

Ankara, 06010, Turkey (Türkiye)
Research Site

Ankara, 06590, Turkey (Türkiye)
Research Site

Ankara, 06800, Turkey (Türkiye)
Research Site

Bursa, 16059, Turkey (Türkiye)
Research Site

Istanbul, 34098, Turkey (Türkiye)
Research Site

Izmir, 35100, Turkey (Türkiye)
Research Site

Chernivtsi, 58013, Ukraine
Research Site

Dnipro, 49102, Ukraine
Research Site

Ivano-Frankivsk, 76018, Ukraine
Research Site

Kyiv, 88014, Ukraine
Research Site

Uzhhorod, 88014, Ukraine
Research Site

Vinnytsia, 21029, Ukraine
Research Site

London, EC1A 7BE, United Kingdom
Research Site

Sheffield, S10 2SJ, United Kingdom
Research Site

Hanoi, 100000, Vietnam
Research Site

Ho Chi Minh City, 70000, Vietnam
Research Site

Hồ Chí Minh, 700000, Vietnam

Conditions

Explore the condition pages connected to this study.

CANCER